Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fimasartan vs Valsartan for Blood Pressure Variability in Acute Ischemic Stroke
KCT0003254Phase 4Active, not recruiting
- Sponsor
- Boryung
- Start
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of fimasartan, valsartan in ischemic stroke, hypertension (HTN), sponsored by Boryung. Started Jul 2015; status: active, not recruiting.
02
Drugs
fimasartanvalsartan
03
Conditions
ischemic strokehypertension (HTN)
Beyond the preview
Go deeper on KCT0003254.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003254.